Relationship among dietary intake of vitamin D, magnesium, and calcium, 25-hydroxyvitamin D levels, and glycemic control markers in individuals with type 2 diabetes
暂无分享,去创建一个
Liliane Viana Pires | V. S. Rocha | Ramara Kadija Fonseca Santos | Beatriz da Cruz Santos | Cynthia Batista Santos | Aline Rocha Reis | G. B. de Carvalho | Cinthia Fontes da Silva Santos | Juliana de Souza Oliveira | Paula Nascimento Brandão-Lima | P. N. Brandão-Lima
[1] P. Karau,et al. The prevalence of vitamin D deficiency among patients with type 2 diabetes seen at a referral hospital in Kenya , 2019, The Pan African medical journal.
[2] H. Hetta,et al. Does vitamin D status correlate with insulin resistance in obese prediabetic patients? An Egyptian multicenter study. , 2019, Diabetes & metabolic syndrome.
[3] P. Shewokis,et al. Low dietary magnesium intake alters vitamin D-parathyroid hormone relationship in adults who are overweight or obese. , 2019, Nutrition research.
[4] M. Yassin,et al. Serum vitamin D status in type 2 diabetic patients from Gaza Strip. , 2019, Diabetes & metabolic syndrome.
[5] S. Basu,et al. Vitamin D status, determinants and relationship with biochemical profile in women with Type 2 Diabetes Mellitus in Delhi, India. , 2019, Diabetes & metabolic syndrome.
[6] A. Rauf,et al. Association Between Low Serum Magnesium Level And Type 2 Diabetes Mellitus In Abbottabad. , 2019, Journal of Ayub Medical College, Abbottabad : JAMC.
[7] Kyong Park,et al. Effects of Consuming Calcium-Rich Foods on the Incidence of Type 2 Diabetes Mellitus , 2018, Nutrients.
[8] Liliane Viana Pires,et al. Intakes of Zinc, Potassium, Calcium, and Magnesium of Individuals with Type 2 Diabetes Mellitus and the Relationship with Glycemic Control , 2018, Nutrients.
[9] G. Samur,et al. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus , 2018, Journal of the American College of Nutrition.
[10] Se-Young Oh,et al. Associations of serum calcium levels and dietary calcium intake with incident type 2 diabetes over 10 years: the Korean Genome and Epidemiology Study (KoGES) , 2018, Diabetology & Metabolic Syndrome.
[11] Kiang Liu,et al. Invited Commentary: Quantifying the Added Value of Repeated Measurements. , 2017, American journal of epidemiology.
[12] R. Garg,et al. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta‐analysis , 2017, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[13] C. E. Negrão,et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017 , 2017 .
[14] Liliane Viana Pires,et al. Vitamin D ratio and glycaemic control in individuals with type 2 diabetes mellitus: A systematic review , 2017, Diabetes/metabolism research and reviews.
[15] X. Fang,et al. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies , 2016, Nutrients.
[16] S. Castells,et al. Genetic Disorders of Vitamin D Metabolism , 2016, Clinical pediatrics.
[17] M. Holick. Vitamin D Is Not as Toxic as Was Once Thought: A Historical and an Up-to-Date Perspective. , 2015, Mayo Clinic proceedings.
[18] Carlos Teles Santos,et al. Obesity and vitamin D deficiency: a systematic review and meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[19] J. Manson,et al. Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III , 2013, BMC Medicine.
[20] Dan Gao,et al. Vitamin D signalling in adipose tissue , 2012, British Journal of Nutrition.
[21] R. Heaney,et al. Volumetric Dilution, Rather Than Sequestration Best Explains the Low Vitamin D Status of Obesity , 2012, Obesity.
[22] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[23] B. Geloneze,et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). , 2009, Arquivos brasileiros de endocrinologia e metabologia.
[24] M. Holick. Vitamin D: a D-Lightful health perspective. , 2008, Nutrition reviews.
[25] M. García-Arencibia,et al. Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats , 2008, BMC Molecular Biology.
[26] Lenildo de Moura,et al. Comportamento relativo à exposição e proteção solar na população de 15 anos ou mais de 15 capitais brasileiras e Distrito Federal, 2002-2003 , 2007 .
[27] A. Zittermann. Vitamin D and disease prevention with special reference to cardiovascular disease. , 2006, Progress in biophysics and molecular biology.
[28] B. Geloneze,et al. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. , 2006, Diabetes research and clinical practice.
[29] J. Manson,et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.
[30] A. Uitterlinden,et al. Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.
[31] E. Wolf,et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] H. DeLuca,et al. Vitamin D Receptor , 2002 .
[33] P. Gilon,et al. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. , 2001, Endocrine reviews.
[34] W. Willett. Issues in Analysis and Presentation of Dietary Data , 1998 .
[35] N. Færgeman,et al. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. , 1997, The Biochemical journal.
[36] E. Feskens,et al. Vitamin D, glucose tolerance and insulinaemia in elderly men , 1997, Diabetologia.
[37] P. Guenther,et al. The multiple-pass approach for the 24-hour recall in the continuing survey of food intakes by individuals 1994-96 , 1996 .
[38] T. Hahn,et al. Vitamin D resistance in magnesium deficiency. , 1976, The American journal of clinical nutrition.
[39] A. Morakinyo,et al. Magnesium upregulates insulin receptor and glucose transporter-4 in streptozotocin-nicotinamide-induced type-2 diabetic rats , 2018, Endocrine regulations.
[40] F. Ashcroft,et al. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. , 2018, Physiological reviews.
[41] C. Tack,et al. Determinants of hypomagnesemia in patients with type 2 diabetes mellitus. , 2017, European journal of endocrinology.
[42] M. Holick. Ultraviolet B Radiation: The Vitamin D Connection. , 2017, Advances in experimental medicine and biology.
[43] J. Allgrove. Physiology of Calcium, Phosphate, Magnesium and Vitamin D. , 2015, Endocrine development.
[44] Uazman Alam,et al. General aspects of diabetes mellitus. , 2014, Handbook of clinical neurology.
[45] G. Chrousos,et al. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: A body mass index-independent role of adiponectin? , 2011, Journal of Endocrinological Investigation.
[46] Aesha Drozdowski,et al. Standards of medical care in diabetes. , 2004, Diabetes care.
[47] Who Consultation on Obesity. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.
[48] R. Boileau. Advances in body composition assessment , 1993 .